{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T16:21:43Z","timestamp":1759940503672},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,4,1]]},"DOI":"10.1093\/ehjcvp\/pvx029","type":"journal-article","created":{"date-parts":[[2017,9,12]],"date-time":"2017-09-12T03:15:56Z","timestamp":1505186156000},"page":"67-68","source":"Crossref","is-referenced-by-count":12,"title":["Trimetazidine: is there a role beyond angina?"],"prefix":"10.1093","volume":"4","author":[{"given":"Jason M","family":"Tarkin","sequence":"first","affiliation":[{"name":"Division of Cardiovascular Medicine, University of Cambridge, Box 110, Addenbrooke's Hospital, Hills Road, Cambridge CB2 0QQ, UK"},{"name":"Department of Cardiology, Barts Heart Centre, St. Bartholomew's Hospital, W Smithfield, London EC1 7BE, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Carlos","family":"Kaski","sequence":"additional","affiliation":[{"name":"Molecular and Clinical Sciences Research Institute, St George's, University of London, Cranmer Terrace SW17 0RE, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2018,3,5]]},"reference":[{"key":"key\n\t\t\t\t20180315060240_pvx029-B1","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1093\/ehjcvp\/pvv051","article-title":"The role of trimetazidine in cardiovascular disease: beyond an anti-anginal agent","volume":"2","author":"McCarthy","year":"2016","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"key\n\t\t\t\t20180315060240_pvx029-B2","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1053\/euhj.2001.2896","article-title":"Combination treatment in stable effort angina using trimetazidine and metoprolol: results of a randomized, double-blind, multicentre study (TRIMPOL II). TRIMetazidine in POLand","volume":"22","author":"Szwed","year":"2001","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180315060240_pvx029-B3","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/00045391-200501000-00006","article-title":"Trimetazidine in Angina Combination Therapy--the TACT study: trimetazidine versus conventional treatment in patients with stable angina pectoris in a randomized, placebo-controlled, multicenter study","volume":"12","author":"Chazov","year":"2005","journal-title":"Am J Ther"},{"key":"key\n\t\t\t\t20180315060240_pvx029-B4","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.ijcard.2012.11.001","article-title":"Efficacy of trimetazidine on functional capacity in symptomatic patients with stable exertional angina--the VASCO-angina study","volume":"168","author":"Vitale","year":"2013","journal-title":"Int J Cardiol"},{"key":"key\n\t\t\t\t20180315060240_pvx029-B5","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1007\/s12325-017-0490-2","article-title":"Real-world evidence for the antianginal efficacy of trimetazidine from\u00a0the\u00a0Russian observational CHOICE-2 Study","volume":"34","author":"Glezer","year":"2017","journal-title":"Adv Ther"},{"key":"key\n\t\t\t\t20180315060240_pvx029-B6","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1093\/eurheartj\/eht296","article-title":"2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology","volume":"34","author":"Task Force Members","year":"2013","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180315060240_pvx029-B7","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.jacc.2011.11.027","article-title":"Additional use of trimetazidine in patients with chronic heart failure: a meta-analysis","volume":"59","author":"Zhang","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20180315060240_pvx029-B8","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1136\/hrt.2010.208751","article-title":"Trimetazidine: a meta-analysis of randomised controlled trials in heart failure","volume":"97","author":"Gao","year":"2011","journal-title":"Heart."},{"key":"key\n\t\t\t\t20180315060240_pvx029-B9","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.ijcard.2012.09.123","article-title":"Effect of partial fatty acid oxidation inhibition with trimetazidine on mortality and morbidity in heart failure: results from an international multicentre retrospective cohort study","volume":"163","author":"Fragasso","year":"2013","journal-title":"Int J Cardiol"},{"key":"key\n\t\t\t\t20180315060240_pvx029-B10","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1093\/cvr\/cvq181","article-title":"Trimetazidine inhibits pressure overload-induced cardiac fibrosis through NADPH oxidase-ROS-CTGF pathway","volume":"88","author":"Liu","year":"2010","journal-title":"Cardiovasc Res"},{"key":"key\n\t\t\t\t20180315060240_pvx029-B11","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1093\/eurheartj\/ehm071","article-title":"Trimetazidine improves endothelial dysfunction in chronic heart failure: an antioxidant effect","volume":"28","author":"Belardinelli","year":"2007","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180315060240_pvx029-B12","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1136\/hrt.2011.226332","article-title":"Effect of partial inhibition of fatty acid oxidation by trimetazidine on whole body energy metabolism in patients with chronic heart failure","volume":"97","author":"Fragasso","year":"2011","journal-title":"Heart"},{"key":"key\n\t\t\t\t20180315060240_pvx029-B13","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0008-6363(96)00112-5","article-title":"Pre-treatment with trimetazidine increases sarcolemmal mechanical resistance in reoxygenated myocytes","volume":"32","author":"Ruiz-Meana","year":"1996","journal-title":"Cardiovasc Res"},{"key":"key\n\t\t\t\t20180315060240_pvx029-B14","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.yjmcc.2005.09.012","article-title":"Trimetazidine inhibits mitochondrial permeability transition pore opening and prevents lethal ischemia-reperfusion injury","volume":"39","author":"Argaud","year":"2005","journal-title":"J Mol Cell Cardiol"},{"key":"key\n\t\t\t\t20180315060240_pvx029-B15","doi-asserted-by":"crossref","first-page":"4216","DOI":"10.3892\/mmr.2016.5773","article-title":"Trimetazidine protects against cardiac ischemia\/reperfusion injury via effects on cardiac miRNA-21 expression, Akt and the Bcl-2\/Bax pathway","volume":"14","author":"Ma","year":"2016","journal-title":"Mol Med Report"},{"key":"key\n\t\t\t\t20180315060240_pvx029-B16","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1023\/A:1007804007115","article-title":"Effects of trimetazidine administration before thrombolysis in patients with anterior myocardial infarction: short-term and long-term results","volume":"13","author":"Di Pasquale","year":"1999","journal-title":"Cardiovasc Drugs Ther"},{"key":"key\n\t\t\t\t20180315060240_pvx029-B17","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1136\/hrt.2006.107524","article-title":"Protective effect of an acute oral loading dose of trimetazidine on myocardial injury following percutaneous coronary intervention","volume":"93","author":"Bonello","year":"2007","journal-title":"Heart"},{"key":"key\n\t\t\t\t20180315060240_pvx029-B18","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1159\/000375289","article-title":"The effectiveness of preoperative trimetazidine on myocardial preservation in coronary artery bypass graft patients: a systematic review and meta-analysis","volume":"131","author":"Zhang","year":"2015","journal-title":"Cardiology"},{"key":"key\n\t\t\t\t20180315060240_pvx029-B19","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0167-5273(00)00443-5","article-title":"A randomized double-blind trial of intravenous trimetazidine as adjunctive therapy to primary angioplasty for acute myocardial infarction","volume":"77","author":"Steg","year":"2001","journal-title":"Int J Cardiol"},{"key":"key\n\t\t\t\t20180315060240_pvx029-B20","doi-asserted-by":"crossref","first-page":"293","DOI":"10.2165\/11316840-000000000-00000","article-title":"Effect of antianginal drugs in stable angina on predicted mortality risk after surviving a myocardial infarction: a preliminary study (METRO)","volume":"9","author":"Iyengar","year":"2009","journal-title":"Am J Cardiovasc Drugs"}],"container-title":["European Heart Journal - Cardiovascular Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ehjcvp\/article-pdf\/4\/2\/67\/24260549\/pvx029.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,3,15]],"date-time":"2018-03-15T10:02:51Z","timestamp":1521108171000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjcvp\/article\/4\/2\/67\/4923311"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,5]]},"references-count":20,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2018,3,5]]},"published-print":{"date-parts":[[2018,4,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjcvp\/pvx029","relation":{},"ISSN":["2055-6837","2055-6845"],"issn-type":[{"value":"2055-6837","type":"print"},{"value":"2055-6845","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,4]]},"published":{"date-parts":[[2018,3,5]]}}}